サンプル依頼リスト カート
  • English
  • Korean
市場調査レポート
商品コード
1480364

RNA標的低分子治療薬の世界市場：2033年までの機会と戦略

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033

出版日
ページ情報
英文 294 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
RNA標的低分子治療薬の世界市場：2033年までの機会と戦略
出版日: 2024年05月16日
発行: The Business Research Company
ページ情報: 英文 294 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

世界のRNA標的低分子治療薬市場は13億4,630万米ドルと評価され、2023年までCAGR28.0％以上で成長しました。

神経疾患の発生率の増加

神経疾患の罹患率の増加は、歴史的な期間にRNA標的低分子創薬市場の成長を促進しました。神経疾患とは、脳、脊髄、神経を含む神経系に影響を及ぼし、運動、感覚、認知、その他の神経機能に障害をもたらす幅広い状態を指します。神経疾患の発生率が増加しているのは、人口の高齢化、環境汚染物質、ライフスタイルの変化、診断能力の向上によりこれまで発見されていなかった症例が発見されるようになったことなどが原因です。RNA標的低分子創薬は、神経疾患の病態に関連するRNA分子を特異的に標的とする治療薬を開発することで、神経疾患への対処を支援するものであり、疾患の進行を調節する新しい治療法を提供する可能性があります。英国を拠点とする生物医学研究機関である国立衛生研究所によると、2019年には神経疾患は世界の疾病負担の3.8％、オーストラリアの疾病負担の6.6％を占め、2022年には神経疾患が負担の8％を占めるのとは対照的です。したがって、神経疾患の発生率の増加が、RNA標的低分子治療薬市場の成長を牽引しました。

目次

第1章 エグゼクティブサマリー

  • RNA標的低分子治療薬- 市場の魅力とマクロ経済情勢

第2章 目次

第3章 表一覧

第4章 図一覧

第5章 レポート構成

第6章 市場の特徴

  • 一般的な市場の定義
  • 概要
  • RNA標的低分子治療薬市場定義とセグメンテーション
  • 製品別：市場セグメンテーション
    • アンチセンスオリゴヌクレオチド（ASO）
    • siRNA
  • 治療適応症別：市場セグメンテーション
    • 筋骨格障害
    • 神経変性疾患
    • 循環器疾患
    • 泌尿生殖器
    • その他の治療適応症
  • エンドユーザー別：市場セグメンテーション
    • 病院
    • 調査室
    • 製薬およびバイオテクノロジー企業
    • その他のエンドユーザー

第7章 主要な市場動向

  • RNA標的低分子治療薬を推進する戦略的コラボレーション
  • 主要プレーヤーがRNA標的低分子治療におけるスタートアップソリューションを採用
  • 創薬におけるRNA標的低分子の効率を高めるための人工知能（AI）の利用
  • RNAを標的とした低分子治療におけるイノベーションを推進するパートナーシップ
  • さまざまな医療分野をターゲットとしたRNA分解治療薬の進歩に焦点を当てる
  • mRNA小分子創薬への注目の高まり
  • 神経疾患治療のためのRNA調節薬の開発

第8章 RNA標的低分子治療薬市場：マクロ経済シナリオ

  • COVID-19の影響： RNA標的低分子治療薬市場
  • ウクライナ戦争の影響： RNA標的低分子治療薬市場
  • 高インフレの影響： RNA標的低分子治療薬市場

第9章 世界の市場規模と成長

  • 市場規模
  • 市場成長実績, 2018-2023
    • 市場促進要因2018-2023
    • 市場抑制要因2018-2023
  • 市場成長予測, 2023-2028, 2033F
    • 市場促進要因2023-2028
    • 市場抑制要因2023-2028

第10章 世界のRNA標的低分子治療薬市場：セグメンテーション

  • 世界のRNA標的低分子治療薬市場：タイプ別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のRNA標的低分子治療薬市場：治療適応症別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のRNA標的低分子治療薬市場：エンドユーザー別、実績と予測, 2018-2023, 2028F, 2033F

第11章 RNA標的低分子治療薬市場：地域・国別分析

  • 世界のRNA標的低分子治療薬市場：地域別、実績と予測, 2018-2023, 2028F, 2033F
  • 世界のRNA標的低分子治療薬市場：国別、実績と予測, 2018-2023, 2028F, 2033F

第12章 アジア太平洋市場

第13章 西欧市場

第14章 東欧市場

第15章 北米市場

第16章 南米市場

第17章 中東市場

第18章 アフリカ市場

第19章 競合情勢と企業プロファイル

  • 企業プロファイル
  • Ionis Pharmaceuticals
  • Alnylam Pharmaceuticals
  • Sarepta Therapeutics
  • Jazz Pharmaceuticals
  • Novartis

第20章 その他の大手企業と革新的企業

  • NS Pharma
  • Arrakis Therapeutics
  • PTC Therapeutics
  • Anima Biotech Inc.
  • Ribometrix
  • Skyhawk Therapeutics Inc.
  • STORM Therapeutics Ltd.
  • Accent Therapeutics
  • Promega Corporation
  • Bayer AG
  • Arrowhead Pharmaceuticals Inc.
  • Abivax SA
  • AC Immune SA
  • Remix Therapeutics
  • 858 Therapeutics

第21章 競合ベンチマーキング

第22章 競合ダッシュボード

第23章 主要な合併と買収

  • Novo Nordisk Acquire DiceRNA Pharmaceuticals
  • Sanofi's Acquired Translate Bio

第24章 機会と戦略

  • 2028年の世界のRNA標的低分子治療薬市場：新たな機会が最も多く生まれる国
  • 2028年の世界のRNA標的低分子治療薬市場：セグメントタイプで最も新しい機会
  • 2028年の世界のRNA標的低分子治療薬市場：成長戦略
    • 市場動向に基づく戦略
    • 競合の戦略

第25章 RNA標的低分子治療薬市場：結論と提言

  • 結論
  • 提言
    • 製品
    • 場所
    • 価格
    • プロモーション
    • 人々

第26章 付録

目次
Product Code: o&s1164

RNA (ribonucleic acid) targeting small molecule therapeutics are a class of pharmaceutical compounds designed to specifically interact with RNA molecules within cells, modulating their function and activity to treat various diseases. RNA molecules play critical roles in gene expression, protein synthesis and cellular regulation and dysregulation of RNA function is implicated in numerous diseases, including cancer, genetic disorders, viral infections and neurodegenerative diseases.

The RNA targeting small molecule therapeutics market consists of sales of RNA targeting small molecule therapeutics by entities (organizations, sole traders or partnerships) that are engaged in the research, development and commercialization of therapeutic agents designed to interact with RNA through various mechanisms. These offerings include mRNA Translation modulators that affect the process by which messenger RNA (mRNA) is translated into proteins, RNA Splicing modifiers that alter the way in which RNA is spliced and various segments are joined together to form mature mRNA, Direct RNA Targeting molecules that bind directly to RNA to affect its function and other innovative approaches to RNA targeting.

The global RNA targeting small molecules therapeutics market was valued at $1,346.3 million in which grew till 2023 at a compound annual growth rate (CAGR) of more than 28.0%.

Increasing Incidence Of Neurological Disorders

The increasing incidence of neurological disorders propelled the growth of the RNA-targeting small molecule drug discovery market during the historic period. Neurological disorders refer to a wide range of conditions that affect the nervous system, including the brain, spinal cord and nerves, leading to impairments in movement, sensation, cognition, or other neurological functions. The increasing incidence of neurological disorders can be attributed to factors such as aging populations, environmental pollutants, lifestyle changes and improved diagnostic capabilities uncovering previously undetected cases. RNA-targeting small molecule drug discovery aids in addressing neurological disorders by developing therapeutics that specifically target RNA molecules associated with the pathology of these disorders, potentially offering novel treatments to modulate disease progression. According to the National Institutes of Health, a UK-based biomedical research agency, in 2019, neurological diseases comprised 3.8% of the global disease burden and 6.6% of Australia's total disease burden, contrasting with neurological conditions, which accounted for 8% of the burden in 2022. Therefore, the increasing incidence of neurological disorders drove the growth of the RNA targeting small molecule therapeutics market.

Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics

Companies in the RNA targeting small molecule therapeutics market are focusing on innovative startup solutions to optimize drug design and enhance RNA-targeted therapeutic development. These solutions facilitate target identification, molecular design and predictive modeling for efficacy and safety to contribute to the health and well-being of all people worldwide. For instance, in February 2024, AION Labs, an Israel-based venture hub for drug discovery and BioMed X, a Germany-based research institute, launched a global call for applications to identify computational biologists, biomedical scientists and inventors to form a new startup at AION Labs. It focuses on the development of an artificial intelligence (AI) and machine learning (ML) computational platform to identify functional regions in RNA that can be targeted with small molecules. RNA has traditionally been deemed unsuitable for small-molecule binding.

The global RNA targeting small molecule therapeutics market is highly concentrated, with a few large players operating in the market. The top ten competitors in the market made up to 98.9% of the total market in 2022.

RNA Targeting Small Molecules Therapeutics Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global RNA targeting small molecules therapeutics market as it emerges from the COVID-19 shut down.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for RNA targeting small molecules therapeutics? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The RNA targeting small molecules therapeutics market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider RNA targeting small molecules therapeutics market; and compares it with other markets.

The report covers the following chapters

  • Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by therapeutic indication and by end-user.
  • Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
  • Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the RNA targeting small molecules therapeutics market.
  • Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
  • Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
  • Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by therapeutic indication and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
  • Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
  • Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
  • Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
  • Competitive Dashboard- Briefs on competitive dashboard of major players.
  • Key Mergers and Acquisitions- Information on recent mergers and acquisitions in the market is covered in the report. This section gives key financial details of mergers and acquisitions which have shaped the market in recent years.
  • Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
  • Conclusions And Recommendations- This section includes recommendations for RNA targeting small molecules therapeutics providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
  • Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

  • 1) By Product: Antisense Oligonucleotides (ASOs); Small Interfering RNA (siRNA)
  • 2) By Therapeutic Indication: Musculoskeletal Disorder; Neurodegenerative Diseases; Cardiovascular Disease; Genito-Urinary; Therapeutic Indications
  • 3) By End User: Hospitals; Research Laboratories; Pharmaceutical and Biotechnology Companies; Other End-Users
  • Companies Mentioned: Ionis Pharmaceuticals; Alnylam Pharmaceuticals; Sarepta Therapeutics; Jazz Pharmaceuticals; Novartis
  • Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time-series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; RNA targeting small molecules therapeutics indicators comparison.
  • Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1 Executive Summary

  • 1.1 RNA Targeting Small Molecule Therapeutics - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

  • 6.1 General Market Definition
  • 6.2 Summary
  • 6.3 RNA Targeting Small Molecules Therapeutics Market Definition And Segmentations
  • 6.4 Market Segmentation By Product
    • 6.4.1 Antisense Oligonucleotides (ASOs)
    • 6.4.2 siRNA
  • 6.5 Market Segmentation By Therapeutic Indication
    • 6.5.1 Musculoskeletal Disorder
    • 6.5.2 Neurodegenerative Diseases
    • 6.5.3 Cardiovascular disease
    • 6.5.4 Genito-Urinary
    • 6.5.5 Other Therapeutic Indications
  • 6.6 Market Segmentation By End-User
    • 6.6.1 Hospitals
    • 6.6.2 Research Laboratories
    • 6.6.3 Pharmaceutical And Biotechnology Companies
    • 6.6.4 Other End-Users

7 Major Market Trends

  • 7.1 Strategic Collaboration Fueling RNA Targeting Small Molecules Therapeutics
  • 7.2 Key Players Embrace Startup Solutions In RNA Targeting Small Molecules Therapeutics
  • 7.3 Use Of Artificial Intelligence (AI) To Enhance Efficiency Of RNA Targeting Small Molecules During Drug Discovery
  • 7.4 Partnerships Driving Innovation In RNA Targeting Small Molecules Therapeutics
  • 7.5 Focus On Advancement In RNA Degrader Therapeutics Targeting For Various Medical Domains
  • 7.6 Increased Focus On mRNA Small Molecule Drug Discovery
  • 7.7 Development Of RNA Modulatory Drugs For Treating Neurological Diseases

8 RNA Targeting Small Molecules Therapeutics Market - Macro Economic Scenario

  • 8.1 COVID-19 Impact On The RNA Targeting Small Molecules Therapeutics Market
  • 8.2 Impact Of The War In Ukraine On The RNA Targeting Small Molecules Therapeutics Market
  • 8.3 Impact Of High Inflation On The RNA Targeting Small Molecules Therapeutics Market

9 Global Market Size and Growth

  • 9.1 Market Size
  • 9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
    • 9.2.1 Market Drivers 2018 - 2023
    • 9.2.2 Market Restraints 2018 - 2023
  • 9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
    • 9.3.1 Market Drivers 2023 - 2028
    • 9.3.2 Market Restraints 2023 - 2028

10 Global RNA Targeting Small Molecules Therapeutics Market Segmentation

  • 10.1 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.2 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 10.3 Global RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 RNA Targeting Small Molecules Therapeutics Market, Regional and Country Analysis

  • 11.1 Global RNA Targeting Small Molecules Therapeutics Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 11.2 Global RNA Targeting Small Molecules Therapeutics Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

  • 12.1 Summary
    • 12.1.1 Market Overview
    • 12.1.2 Region Information
    • 12.1.3 Market Information
    • 12.1.4 Background Information
    • 12.1.5 Government Initiatives
    • 12.1.6 Regulations
    • 12.1.7 Regulatory Bodies
    • 12.1.8 Major Associations
    • 12.1.9 Taxes Levied
    • 12.1.10 Corporate Tax Structure
    • 12.1.11 Investments
    • 12.1.12 Major Companies
  • 12.2 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.3 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.4 Asia-Pacific RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.5 Asia-Pacific RNA targeting Small Molecules Therapeutics Market: Country Analysis
  • 12.6 China Market
  • 12.7 Summary
    • 12.7.1 Market Overview
    • 12.7.2 Country Information
    • 12.7.3 Market Information
    • 12.7.4 Background Information
    • 12.7.5 Government Initiatives
    • 12.7.6 Regulations
    • 12.7.7 Regulatory Bodies
    • 12.7.8 Major Associations
    • 12.7.9 Taxes Levied
    • 12.7.10 Corporate Tax Structure
    • 12.7.11 Investments
    • 12.7.12 Major Companies
  • 12.8 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.9 China RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.10 China RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.11 India Market
  • 12.12 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.13 India RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.14 India RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.15 Japan Market
  • 12.16 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.17 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.18 Japan RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.19 Australia Market
  • 12.20 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.21 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.22 Australia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.23 Indonesia Market
  • 12.24 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.25 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.26 Indonesia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.27 South Korea Market
  • 12.28 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.29 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 12.30 South Korea RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

  • 13.1 Summary
    • 13.1.1 Market Overview
    • 13.1.2 Region Information
    • 13.1.3 Market Information
    • 13.1.4 Background Information
    • 13.1.5 Government Initiatives
    • 13.1.6 Regulations
    • 13.1.7 Regulatory Bodies
    • 13.1.8 Major Associations
    • 13.1.9 Taxes Levied
    • 13.1.10 Corporate Tax Structure
    • 13.1.11 Investments
    • 13.1.12 Major Companies
  • 13.2 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.3 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.4 Western Europe RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.5 Western Europe RNA Targeting Small Molecules Therapeutics Market: Country Analysis
  • 13.6 UK Market
  • 13.7 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.8 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.9 UK RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.10 Germany Market
  • 13.11 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.12 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.13 Germany RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.14 France Market
  • 13.15 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.16 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.17 France RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.18 Italy Market
  • 13.19 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.20 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.21 Italy RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.22 Spain Market
  • 13.23 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.24 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 13.25 Spain RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

  • 14.1 Summary
    • 14.1.1 Market Overview
    • 14.1.2 Region Information
    • 14.1.3 Market Information
    • 14.1.4 Background Information
    • 14.1.5 Government Initiatives
    • 14.1.6 Regulations
    • 14.1.7 Regulatory Bodies
    • 14.1.8 Major Associations
    • 14.1.9 Taxes Levied
    • 14.1.10 Corporate Tax Structure
    • 14.1.11 Major Companies
  • 14.2 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.3 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.4 Eastern Europe RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.5 Eastern Europe RNA targeting Small Molecules Therapeutics Market: Country Analysis
  • 14.6 Russia Market
  • 14.7 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.8 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 14.9 Russia RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

  • 15.1 Summary
    • 15.1.1 Market Overview
    • 15.1.2 Region Information
    • 15.1.3 Market Information
    • 15.1.4 Background Information
    • 15.1.5 Government Initiatives
    • 15.1.6 Regulations
    • 15.1.7 Regulatory Bodies
    • 15.1.8 Major Associations
    • 15.1.9 Taxes Levied
    • 15.1.10 Corporate Tax Structure
    • 15.1.11 Investments
    • 15.1.12 Major Companies
  • 15.2 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.3 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.4 North America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.5 North America RNA targeting Small Molecules Therapeutics Market: Country Analysis
  • 15.6 USA Market
  • 15.7 Summary
    • 15.7.1 Market Overview
    • 15.7.2 Country Information
    • 15.7.3 Market Information
    • 15.7.4 Background Information
    • 15.7.5 Government Initiatives
    • 15.7.6 Regulations
    • 15.7.7 Regulatory Bodies
    • 15.7.8 Major Associations
    • 15.7.9 Taxes Levied
    • 15.7.10 Corporate Tax Structure
    • 15.7.11 Investments
    • 15.7.12 Major Companies
  • 15.8 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.9 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.10 USA RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.11 Canada Market
  • 15.12 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.13 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 15.14 Canada RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

  • 16.1 Summary
    • 16.1.1 Market Overview
    • 16.1.2 Region Information
    • 16.1.3 Market Information
    • 16.1.4 Background Information
    • 16.1.5 Government Initiatives
    • 16.1.6 Regulations
    • 16.1.7 Regulatory Bodies
    • 16.1.8 Major Associations
    • 16.1.9 Taxes Levied
    • 16.1.10 Corporate Tax Structure
    • 16.1.11 Investments
    • 16.1.12 Major Companies
  • 16.2 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.3 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.4 South America RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.5 South America RNA targeting Small Molecules Therapeutics Market: Country Analysis
  • 16.6 Brazil Market
  • 16.7 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.8 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 16.9 Brazil RNA targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

  • 17.1 Summary
    • 17.1.1 Market Overview
    • 17.1.2 Region Information
    • 17.1.3 Market Information
    • 17.1.4 Background Information
    • 17.1.5 Government Initiatives
    • 17.1.6 Regulations
    • 17.1.7 Regulatory Bodies
    • 17.1.8 Major Associations
    • 17.1.9 Taxes Levied
    • 17.1.10 Corporate Tax Structure
    • 17.1.11 Investments
    • 17.1.12 Major Companies
  • 17.2 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.3 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 17.4 Middle East RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

  • 18.1 Summary
  • 18.2 Market Overview
    • 18.2.1 Region Information
    • 18.2.2 Market Information
    • 18.2.3 Background Information
    • 18.2.4 Government Initiatives
    • 18.2.5 Regulations
    • 18.2.6 Regulatory Bodies
    • 18.2.7 Major Associations
    • 18.2.8 Taxes Levied
    • 18.2.9 Corporate Tax Structure
    • 18.2.10 Major Companies
  • 18.3 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.4 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By Therapeutic Indication, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
  • 18.5 Africa RNA Targeting Small Molecules Therapeutics Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

  • 19.1 Company Profiles
  • 19.2 Ionis Pharmaceuticals
    • 19.2.1 Company Overview
    • 19.2.2 Products And Services
    • 19.2.3 Business Strategy
    • 19.2.4 Financial performance
  • 19.3 Alnylam Pharmaceuticals
    • 19.3.1 Company Overview
    • 19.3.2 Products And Services
    • 19.3.3 Business Strategy
    • 19.3.4 Financial performance
  • 19.4 Sarepta Therapeutics
    • 19.4.1 Company Overview
    • 19.4.2 Products And Services
    • 19.4.3 Business Strategy
    • 19.4.4 Financial performance
  • 19.5 Jazz Pharmaceuticals
    • 19.5.1 Company Overview
    • 19.5.2 Products And Services
    • 19.5.3 Financial performance
  • 19.6 Novartis
    • 19.6.1 Company Overview
    • 19.6.2 Products And Services
    • 19.6.3 Business Strategy
    • 19.6.4 Financial performance

20 RNA Targeting Small Molecules Therapeutics Market Other Major And Innovative Companies

  • 20.1 NS Pharma
    • 20.1.1 Company Overview
    • 20.1.2 Products And Services
  • 20.2 Arrakis Therapeutics
    • 20.2.1 Company Overview
    • 20.2.2 Products And Services
  • 20.3 PTC Therapeutics
    • 20.3.1 Company Overview
    • 20.3.2 Products And Services
  • 20.4 Anima Biotech Inc.
    • 20.4.1 Company Overview
    • 20.4.2 Products And Services
  • 20.5 Ribometrix
    • 20.5.1 Company Overview
    • 20.5.2 Products And Services
  • 20.6 Skyhawk Therapeutics Inc.
    • 20.6.1 Company Overview
    • 20.6.2 Products And Services
  • 20.7 STORM Therapeutics Ltd.
    • 20.7.1 Company Overview
    • 20.7.2 Products And Services
  • 20.8 Accent Therapeutics
    • 20.8.1 Company Overview
    • 20.8.2 Products And Services
  • 20.9 Promega Corporation
    • 20.9.1 Company Overview
    • 20.9.2 Products And Services
  • 20.10 Bayer AG
    • 20.10.1 Company Overview
    • 20.10.2 Products And Services
  • 20.11 Arrowhead Pharmaceuticals Inc.
    • 20.11.1 Company Overview
    • 20.11.2 Products And Services
  • 20.12 Abivax SA
    • 20.12.1 Company Overview
    • 20.12.2 Products And Services
  • 20.13 AC Immune SA
    • 20.13.1 Company Overview
    • 20.13.2 Products And Services
  • 20.14 Remix Therapeutics
    • 20.14.1 Company Overview
    • 20.14.2 Products And Services
  • 20.15 858 Therapeutics
    • 20.15.1 Company Overview
    • 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

  • 23.1 Novo Nordisk Acquire DiceRNA Pharmaceuticals
  • 23.2 Sanofi's Acquired Translate Bio

24 Opportunities And Strategies

  • 24.1 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Countries Type Most New Opportunities
  • 24.2 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Segments Type Most New Opportunities
  • 24.3 Global RNA Targeting Small Molecules Therapeutics Market In 2028 - Growth Strategies
    • 24.3.1 Market Trend Based Strategies
    • 24.3.2 Competitor Strategies

25 RNA Targeting Small Molecules Therapeutics Market, Conclusions And Recommendations

  • 25.1 Conclusions
  • 25.2 Recommendations
    • 25.2.1 Product
    • 25.2.2 Place
    • 25.2.3 Price
    • 25.2.4 Promotion
    • 25.2.5 People

26 Appendix

  • 26.1 Geographies Covered
  • 26.2 Market Data Sources
  • 26.3 Research Methodology
  • 26.4 Currencies
  • 26.5 The Business Research Company
  • 26.6 Copyright and Disclaimer